Medtronic (MDT) Cash & Equivalents Growth (1y) (2014 - 2026)

Medtronic (MDT) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 4.15%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 24.05%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -7.50%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -7.71%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 156.03%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -69.36%

Historic Data

Download Data
DateValue
Jan 23, 2026 -7.50%
Oct 24, 2025 -8.03%
Jul 25, 2025 -2.90%
Apr 25, 2025 72.74%
Jan 24, 2025 -23.60%
Oct 25, 2024 6.33%
Jul 26, 2024 -2.09%
Apr 26, 2024 -16.79%
Jan 26, 2024 -64.10%
Oct 27, 2023 -72.85%
Jul 28, 2023 -37.43%
Apr 28, 2023 -58.45%
Jan 27, 2023 29.95%
Oct 28, 2022 66.48%
Jul 29, 2022 -28.76%
Apr 29, 2022 3.37%
Jan 28, 2022 -31.48%
Oct 29, 2021 -54.83%
Jul 30, 2021 -53.78%
Apr 30, 2021 -13.21%